Search for the latest oncology news by tumour type
Young patients with chronic lymphocytic leukaemia (CLL) can enjoy long remissions on the drug ibrutinib, but must stay on it indefinitely to…
Men who inherit an increased risk of cancer through ‘Lynch syndrome’ could benefit from regular…
A Tulane University researcher in the USA found that artificial intelligence can accurately detect and…
A nationwide effort to adequately vaccinate 8 in 10 adolescents against the human papillomavirus (HPV)…
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised…
A drug combination can safely prevent transplanted stem cells (graft) from attacking the recipient’s (host)…
A new study led by João T. Barata from Instituto de Medicina Molecular João Lobo…
Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim…
New evidence suggests that adding the targeted therapy ibrutinib (Imbruvica) to a standard chemotherapy regimen…
In a phase III trial, a combination of ivosidenib and azacitidine was found superior in…